Our Chief Commercial Officer Marcel van Berkel participated as a speaker at the ABLC Conference in Washington on 17 February.

He announced the acquisition by GFBiochemicals of Segetis’ assets and intellectual properties, which include a pilot plant in Minnesota and over 250 worldwide patents.

Marcel van Berkel also focused on ...

Read more